Kensey Nash TriActiv
This article was originally published in The Gray Sheet
Executive Summary
Full European launch of the distal protection system is slated for May through a direct sales force as well as distributors. CE mark approval is announced Jan. 29. The balloon-protected flush extraction system is designed to prevent heart attacks during treatment for blocked saphenous vein grafts (SVGs) in previous coronary bypass patients. The device incorporates a distal protection balloon guidewire, flush catheter and debris extraction system. The firm is in the process of enrolling 800 patients at 50 centers in the U.S. trial...